Insight
Immunogenicity Testing: From Standardized Paradigms to Fit-for-Purpose Bioanalytical Strategies
As biotherapeutics continue to evolve, so must the way immunogenicity is assessed. This white paper explores the industry's shift from traditional, one-size-fits-all immunogenicity testing paradigms toward risk-based, fit-for-purpose strategies that align testing with molecule type, mechanism of action, patient population, and clinical relevance. Readers will gain practical insights into:
- Why immunogenicity risk should drive testing strategy
Learn how therapeutic modality, mechanism of action, patient biology, and intended data use can influence the appropriate immunogenicity testing approach. - When traditional testing may add complexity without additional insight
Discover emerging perspectives on cut points, confirmatory assays, titers, and neutralizing antibody testing, and understand when streamlined approaches may provide sufficient scientific value. - How to implement fit-for-purpose strategies while remaining regulatory-ready
Explore ways to align immunogenicity assessment with clinical relevance while maintaining robust, defensible, and scientifically justified testing programs.
Download Document
Related Insights
ADME Services
Accelerating your drug discovery, preclinical and clinical programs
Bioanalytical Automation of Samples
Taking an assay from bench to an automated platform
Bioanalytical Automation of Samples
Taking an assay from bench to an automated platform
Developing Assays for Novel Drugs
Current science regarding hybrid assays, why they are considered the next "big thing," the technical challenges, and the regulatory impact of these assays.
Strategies for Effective Neutralizing Cell Based Assays in Early Immunogenicity Risk Assessment
Quantitative Assays for Peptides using LC-MS
Quantitative high-throughput analysis of peptide therapeutics and biomarkers to regulated bioanalytical standards
Hybrid Assays for Protein Bioanalysis
Assays and Why Are They Essential for Protein Bioanalysis?
Bioanalysis for Immuno Oncology with Mike Brown
I-O clinical development podcast series
IQVIA Laboratories Corporate Brochure
A global drug discovery and development laboratory services organization
Assay Development for Large-Scale Clinical Studies
Bioanalytical expertise to support large-scale, international studies
